4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001873392-26-000004
President & COO sold 15,000 shares at $15.33 ($229,953)
- President & COO acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J President & COO | 2026-05-04 | Option exercise 10b5-1 | +15,000 | $1.74 | $26,100 | 213,588 | D |
| Dowden Nathan J President & COO | 2026-05-04 | Sale 10b5-1 | −15,000 | $15.33 | $229,953 | 198,588 | D |
| Derivatives | |||||||
| Dowden Nathan J President & COO | 2026-05-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 49,831 | D | ||
| Open-market sales · 15,000 sh · avg $15.33 · $229,953 | |||||||
Loading xslF345X06/wk-form4_1777937054.xml…